Limb-girdle muscular dystrophy
Limb-girdle muscular dystrophy Classification and external resources ICD-10 G71.0 ICD-9 359.1 DiseasesDB 32189 eMedicine neuro/189 MeSH D049288
Limb-girdle muscular dystrophy or Erb's muscular dystrophy is an autosomal class of muscular dystrophy that is similar but distinct from Duchenne muscular dystrophy and Becker's muscular dystrophy. Limb-girdle muscular dystrophy encompasses a large number of rare disorders.
The term "limb-girdle" is used to describe these disorders because the muscles most severely affected are generally those of the hips and shoulders -- the limb girdle muscles.
The muscle weakness is generally symmetric, proximal, and slowly progressive.
In most cases, pain is not present with LGMD, and mental function is not affected.
LGMD can begin in childhood, adolescence, young adulthood or even later. The age of onset is usually between 10 and 30. Both genders are affected equally. When limb-girdle muscular dystrophy begins in childhood the progression appears to be faster and the disease more disabling. When the disorder begins in adolescence or adulthood the disease is generally not as severe and progresses more slowly.
There is no sensory neuropathy or autonomic or visceral disfunction at presentation.the specific dermatomes affected can be demonstrated clinically,and although lower limb deep tendon reflexes and plantar reflex are lost, abdominal reflexes are preserved
The distal muscles are affected late in LGMD, if at all. Over time (usually many years), the person with LGMD loses muscle bulk and strength. Eventually, s/he may need a power wheelchair or scooter, especially for long distances. The various forms of LGMD are highly variable, and can be variable even among persons with the same form of LGMD. In its most severe form, LGMD2C, the symptoms are usually similar to Duchenne Muscular Dystrophy, with individuals losing the ability to walk between ages 10 and 12.
While LGMD isn't typically a fatal disease, it may eventually weaken the heart and respiratory muscles, leading to illness or death due to secondary disorders. In its most severe form, LGMD2C, lifespans are typically limited to the 20s or early 30s.
A person need to perform "Muscle biopsy" test in order to know whether he has muscular dystrophy or not , "Genetic testing" need to be done in order to find the type of LGMD
Currently a "CHIP" is being developed by an organization called "NMD CHIP"
The project is designing chips for the diagnosis of mutations already known to cause Duchenne / Becker muscular dystrophies (DMD/BMD), limb girdle muscular dystrophies (LGMD), congenital muscular dystrophies (CMD), and hereditary motor-sensory neuropathies or Charcot-Marie-Tooth neuropathies (CMT). These diagnostic chips are described as "known-gene chips".
A project website has been set up at www.nmd-chip.eu which enables dissemination of information about the project to stakeholders.
LGMD is typically an inherited disorder, though it may be inherited as a dominant, recessive, or X-linked genetic defect. The result of the defect is that the muscles cannot properly form the proteins needed for normal muscle function. Several different proteins can be affected, and the specific protein that is absent or defective identifies the specific type of muscular dystrophy. Among the proteins affected are α, β, γ and δ sarcoglycans. The sarcoglycanopathies could be possibly amenable to gene therapy.
Treatment for LGMD is primarily supportive. Exercise and physical therapy are advised to maintain as much muscle strength and joint flexibility as possible. Calipers may be used to maintain mobility and quality of life. Careful attention to lung and heart health is also required. IVIg may increase strength in some forms and prevent progression in others, possibly through the prevention of fibrosis and inflammation without the secondary weakening caused by corticosteroids.
There is currently not an effective treatment or cure to address the underlying genetic defects that cause LGMD. There is a variety of research underway targeted at various forms of LGMD. Methods thought to hold significant promise for an effective treatment include "exon skipping" and gene therapy. Several clinical trials are underway and seeking to apply these methodologies to various limb girdly dystrophies.
List of limb-girdle muscular dystrophies
The "LGMD1" family is autosomal dominant, and the "LGMD2" family is autosomal recessive.
Name OMIM Location LGMD1A 159000 TTID LGMD1B 159001 LMNA LGMD1C 607801 CAV3 LGMD1D 603511 7q LGMD1E 602067 6q23 LGMD1F 608423 7q32.1-q32.2 LGMD1G 609115 4q21 LGMD2A 253600 CAPN3 LGMD2B 253601 DYSF LGMD2C 253700 SGCG LGMD2D 608099 SGCA LGMD2E 604286 SGCB LGMD2F 601287 SGCD LGMD2G 601954 TCAP LGMD2H 254110 TRIM32 LGMD2I 607155 FKRP LGMD2J 608807 TTN LGMD2K 609308 POMT1 LGMD2L 611307 ANO5 LGMD2M 611588 FKTN LGMD2N 607439 POMT2 LGMD2O 606822 POMGNT1
- Muscular Dystrophy Association
- LGMD in MDA website
- GeneReviews/NCBI/NIH/UW entry on Limb-Girdle Muscular Dystrophy Overview
- GeneReviews/NCBI/NIH/UW entry on Calpainopathy
- GeneReviews/NCBI/NIH/UW entry on Dysferlinopathy including Miyoshi Distal Myopathy (Miyoshi Myopathy), Limb-Girdle Muscular Dystrophy Type 2B (LGMD2B)
- Healthline for Patients
- Washington University in St. Louis Neuromuscular Section LGMD
- Duke University (Great Clinical Description of LGMD phenotypes
- Glenn Lopate MD for emedicine
- Jain Foundation Inc:Orchestrating a cure for Miyoshi/LGMD2B
- Kurt+Peter Foundation: Raising funds for a cure for LGMD2C
Muscular dystrophy The Nine Primary Muscular DystrophiesRelated topics National/International Organizations US government Institutes and Legislation National/International Events Recent or Ongoing Clinical Trials Diseases of myoneural junction and muscle / neuromuscular disease (G70–G73, 358–359) Neuromuscular-
junction diseaseautoimmune (Myasthenia gravis, Lambert–Eaton myasthenic syndrome)
congenital myopathyMuscular dystrophy
Vesicle formation Rab Cytoskeleton Vesicle fusionDYSF (Distal muscular dystrophy) Arrestin MyelinPelizaeus–Merzbacher disease · Dejerine-Sottas disease · Charcot–Marie–Tooth disease 1B, 2J Pulmonary surfactant Cell adhesion molecule TetraspaninTSPAN7 (X-Linked mental retardation 58) · TSPAN12 (Familial exudative vitreoretinopathy 5) Other
Wikimedia Foundation. 2010.
Look at other dictionaries:
limb-girdle muscular dystrophy — a group of disorders characterized by progressive weakness and wasting in the pelvic girdle (pelvifemoral muscular dystrophy) or shoulder girdle (scapulohumeral muscular dystrophy). It occurs in various subtypes, some of which are of autosomal… … Medical dictionary
limb-girdle muscular dystrophy — noun an autosomal recessive form of muscular dystrophy that appears anywhere from late childhood to middle age; characterized by progressive muscular weakness beginning either in the shoulder or pelvic girdle; usually progresses slowly with… … Useful english dictionary
Muscular dystrophy — Classification and external resources ICD 10 G71.0 ICD 9 359.0 … Wikipedia
Muscular Dystrophy Canada — (MDC) (French: Dystrophie musculaire Canada) is a non profit organization that strives to find a cure for neuromuscular disorders. Founded in 1954 as Muscular Dystrophy Association of Canada, volunteers and staff nation wide have helped to… … Wikipedia
Muscular Dystrophy Association — The Muscular Dystrophy Association (MDA) is an American organization which combats muscular dystrophy and diseases of the nervous system and muscular system in general by funding research, providing medical and community services, and educating… … Wikipedia
Muscular Dystrophy Community Assistance Research and Education Amendments of 2001 — MDCC redirects here. It is also the roman numeral for 1700. The Muscular Dystrophy Community Assistance Research and Education Amendments of 2001 ( MD CARE Act , Pub.L. 107 84, H.R. 717, 115 Stat. 823, enacted December 18, 2001)… … Wikipedia
muscular dystrophy — noun any of several hereditary diseases of the muscular system characterized by weakness and wasting of skeletal muscles (Freq. 2) • Syn: ↑dystrophy • Hypernyms: ↑genetic disease, ↑genetic disorder, ↑genetic abnormality, ↑genetic defect … Useful english dictionary
muscular dystrophy — n any of a group of hereditary diseases characterized by progressive wasting of muscles called also progressive muscular dystrophy see BECKER MUSCULAR DYSTROPHY, DUCHENNE MUSCULAR DYSTROPHY * * * a group of muscl … Medical dictionary
muscular dystrophy — Pathol. a hereditary disease characterized by gradual wasting of the muscles with replacement by scar tissue and fat, sometimes also affecting the heart. [1865 70] * * * Inherited disease that causes progressive weakness in the skeletal (and… … Universalium
Muscular dystrophy, limb-girdle — A form of muscular dystrophy that begins in the patient’s teens or twenties, starting with progressive weakness in the hips or shoulders. A wheelchair is usually needed within 20 years. Limb girdle MD can be caused by any of several genetic… … Medical dictionary